O	0	6	Effect
O	7	9	of
B-intervention	10	14	yoga
I-intervention	15	23	exercise
O	24	26	on
O	27	30	the
B-condition	31	38	quality
I-condition	39	41	of
I-condition	42	46	life
I-condition	47	50	and
I-condition	51	56	upper
I-condition	57	66	extremity
I-condition	67	73	volume
O	74	79	among
O	80	85	women
O	86	90	with
O	91	97	breast
O	98	104	cancer
O	105	112	related
B-condition	113	123	lymphedema
O	123	124	:
O	125	126	A
O	127	132	pilot
O	133	138	study
O	138	139	.

O	140	144	This
O	145	150	pilot
O	151	156	study
O	157	162	aimed
O	163	165	to
O	166	174	evaluate
O	175	178	the
O	179	185	effect
O	186	188	of
O	189	191	an
O	192	193	8
O	193	194	-
O	194	199	weeks
O	199	200	-
O	200	204	yoga
O	205	217	intervention
O	218	220	on
O	221	228	quality
O	229	231	of
O	232	236	life
O	237	240	and
O	241	246	upper
O	247	256	extremity
O	257	262	edema
O	263	269	volume
O	270	272	in
O	273	278	women
O	279	283	with
O	284	290	breast
O	291	297	cancer
O	298	305	related
O	306	316	lymphedema
O	316	317	.

O	318	322	This
O	323	326	was
O	327	328	a
O	329	339	controlled
O	340	345	trial
O	346	350	with
O	351	354	pre
O	354	355	-
O	355	359	post
O	360	366	design
O	366	367	.

O	368	369	A
O	370	375	total
O	376	378	of
B-total-participants	379	381	40
B-eligibility	382	387	women
I-eligibility	388	392	with
I-eligibility	393	399	breast
I-eligibility	400	406	cancer
I-eligibility	407	414	related
I-eligibility	415	425	lymphedema
O	426	430	were
O	431	439	randomly
O	440	448	assigned
O	449	453	into
O	454	456	an
O	457	469	intervention
O	470	472	or
B-control	473	480	control
I-control	481	487	groups
O	487	488	.

O	489	492	The
O	493	505	intervention
O	506	511	group
O	512	524	participated
O	525	527	in
O	528	529	a
O	530	534	yoga
O	535	543	exercise
O	544	549	class
O	550	553	for
O	554	555	8
O	556	561	weeks
O	561	562	,
O	563	565	in
O	566	567	a
O	568	573	twice
O	574	575	a
O	576	580	week
O	581	591	instructor
O	591	592	-
O	592	595	led
O	596	604	practice
O	605	608	and
O	609	613	once
O	614	615	a
O	616	620	week
O	621	625	home
O	626	634	practice
O	634	635	.

O	636	644	Outcomes
O	645	649	were
O	650	655	EORTC
O	656	659	QLQ
O	659	660	_
O	660	663	C30
O	664	666	to
O	667	674	measure
O	675	682	quality
O	683	685	of
O	686	690	life
O	690	691	,
O	692	695	and
O	696	701	water
O	702	714	displacement
O	715	721	volume
O	721	722	-
O	722	727	meter
O	728	730	to
O	731	738	measure
O	739	744	upper
O	745	754	extremity
O	755	760	edema
O	761	767	volume
O	767	768	.

O	769	772	The
O	773	781	outcomes
O	782	786	were
O	787	796	evaluated
O	797	799	at
O	800	808	baseline
O	808	809	,
O	810	813	4th
O	814	817	and
O	818	821	8th
O	822	826	week
O	826	827	.

O	828	832	Data
O	833	837	were
O	838	846	analyzed
O	847	852	using
O	853	857	SPSS
O	857	858	.

O	859	863	Four
O	864	869	weeks
O	870	875	after
O	876	879	the
O	880	892	intervention
O	892	893	,
O	894	895	a
O	896	907	significant
O	908	918	difference
O	919	922	was
O	923	931	observed
O	932	939	between
O	940	943	the
O	944	950	groups
O	951	955	with
O	956	963	respect
O	964	966	to
B-outcome	967	971	role
I-outcome	972	983	functioning
I-outcome	984	986	of
I-outcome	987	994	quality
I-outcome	995	997	of
I-outcome	998	1002	life
O	1003	1004	(
O	1004	1005	P
O	1006	1007	=
O	1008	1009	0
O	1009	1010	.
O	1010	1012	03
O	1012	1013	)
O	1013	1014	.

O	1015	1020	Eight
O	1021	1026	weeks
O	1027	1032	after
O	1033	1036	the
O	1037	1049	intervention
O	1049	1050	,
O	1051	1052	a
O	1053	1064	significant
O	1065	1075	difference
O	1076	1079	was
O	1080	1088	observed
O	1089	1096	between
O	1097	1103	groups
O	1104	1114	concerning
B-outcome	1115	1123	physical
I-outcome	1124	1127	and
I-outcome	1128	1137	emotional
I-outcome	1138	1149	functioning
I-outcome	1150	1152	of
I-outcome	1153	1160	quality
I-outcome	1161	1163	of
I-outcome	1164	1168	life
O	1169	1170	(
O	1170	1171	P
O	1172	1173	<
O	1174	1175	0
O	1175	1176	.
O	1176	1178	05
O	1178	1179	)
O	1179	1180	.

O	1181	1184	The
B-outcome	1185	1193	changing
I-outcome	1194	1199	trend
I-outcome	1200	1202	in
I-outcome	1203	1211	physical
I-outcome	1211	1212	,
I-outcome	1213	1217	role
I-outcome	1217	1218	,
I-outcome	1219	1228	emotional
I-outcome	1228	1229	,
I-outcome	1230	1233	and
I-outcome	1234	1243	cognitive
I-outcome	1244	1255	functioning
O	1256	1259	had
O	1260	1269	increased
O	1269	1270	,
O	1271	1274	and
O	1275	1277	in
O	1278	1282	some
O	1283	1289	scales
O	1290	1294	such
O	1295	1297	as
B-outcome	1298	1305	fatigue
I-outcome	1305	1306	,
I-outcome	1307	1311	pain
I-outcome	1311	1312	,
I-outcome	1313	1321	insomnia
I-outcome	1321	1322	,
I-outcome	1323	1326	and
I-outcome	1327	1336	financial
I-outcome	1337	1349	difficulties
O	1350	1353	the
O	1354	1360	scores
O	1361	1365	were
O	1366	1373	reduced
O	1374	1376	in
O	1377	1380	the
O	1381	1393	intervention
O	1394	1399	group
O	1399	1400	.

O	1401	1410	Regarding
B-outcome	1411	1416	edema
I-outcome	1417	1423	volume
O	1423	1424	,
O	1425	1427	no
O	1428	1439	significant
O	1440	1450	difference
O	1451	1454	was
O	1455	1460	found
O	1461	1468	between
O	1469	1473	both
O	1474	1480	groups
O	1481	1483	on
O	1484	1487	the
O	1488	1491	4th
O	1492	1495	and
O	1496	1499	8th
O	1500	1504	week
O	1505	1510	after
O	1511	1514	the
O	1515	1527	intervention
O	1528	1529	(
O	1529	1530	P
O	1531	1532	>
O	1533	1534	0
O	1534	1535	.
O	1535	1537	05
O	1537	1538	)
O	1538	1539	.

O	1540	1542	As
O	1543	1547	yoga
O	1548	1556	exercise
O	1557	1562	might
O	1563	1570	improve
O	1571	1579	physical
O	1579	1580	,
O	1581	1585	role
O	1585	1586	,
O	1587	1590	and
O	1591	1600	emotional
O	1601	1612	functioning
O	1613	1615	of
O	1616	1623	quality
O	1624	1626	of
O	1627	1631	life
O	1632	1634	as
O	1635	1639	well
O	1640	1642	as
O	1643	1649	reduce
O	1650	1657	fatigue
O	1657	1658	,
O	1659	1663	pain
O	1663	1664	,
O	1665	1668	and
O	1669	1677	insomnia
O	1677	1678	,
O	1679	1684	using
O	1685	1689	this
O	1690	1702	intervention
O	1703	1706	can
O	1707	1709	be
O	1710	1719	suggested
O	1720	1727	amongst
O	1728	1733	women
O	1734	1738	with
O	1739	1745	breast
O	1746	1752	cancer
O	1753	1760	related
O	1761	1771	lymphedema
O	1771	1772	.
